Ray Co

Ray Co Long-term Debt

The Long-Term Debt of Ray Co (228670.KQ) as of Nov 18, 2026 is 672.00 M KRW. In the previous year, Long-Term Debt was 17.95 B KRW — a change of -96.26% (lower).

Long-term Debt

672.00 MKRW

YoY

-96.26%

Last updated:

Long-Term Debt of Ray Co is 2025 672.00 M KRW. Long-Term Debt of Ray Co was 2024 17.95 B KRW. It decreases by -96.26% lower compared to the previous year.

The Ray Co Long-term Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Long-term Debt
Date
Long-term Debt
Jan 1, 2018
0.00 KRW
Jan 1, 2019
2.13 B KRW
Jan 1, 2020
904.66 M KRW
Jan 1, 2021
48.42 B KRW
Jan 1, 2022
37.16 B KRW
Jan 1, 2023
5.09 B KRW
Jan 1, 2024
17.95 B KRW
Jan 1, 2025
672.00 M KRW
The Ray Co Long-term Debt history
YEARLong-term DebtYoY
672.00 MKRW-96.26%
17.95 BKRW+252.39%
5.09 BKRW-86.29%
37.16 BKRW-23.26%
48.42 BKRW+5,252.46%
904.66 MKRW-57.59%
2.13 BKRW—
0.00KRW—
0.00KRW—
0.00KRW—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ray Co Stock analysis

What does Ray Co do? Ray Co., Ltd. generates revenue through the manufacturing and sale of advanced technology medical devices, focusing on digital diagnostic systems and digital therapy solutions. The company produces dental radiography equipment such as x-ray systems and cone beam computed tomography (CBCT) systems, alongside 3D scanning, dental computer aided design (CAD), and 3D printers for prosthodontics, orthodontics, and implant surgery. Domestic and overseas markets purchase these products, with the company operating through subsidiaries to distribute its offerings globally. Digital diagnostic systems like dental radiography equipment and CBCT systems are sold to healthcare providers and dental clinics, while digital therapy solutions including 3D scanning and CAD systems target dental laboratories and surgical centers. The firm's product portfolio serves both domestic and international clients, leveraging its subsidiaries for global distribution channels. Ray Co., Ltd. emphasizes advanced technology in its medical device offerings, with digital therapy solutions such as 3D printers and CAD systems being key revenue drivers. The company's focus on dental-specific applications ensures targeted sales to specialized healthcare segments, including prosthodontics, orthodontics, and implant surgery practices. Ray Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Ray Co stock

Long-Term Debt of Ray Co is 672.00 M KRW in 2025.

Long-Term Debt of Ray Co changed from 17.95 B KRW to 672.00 M KRW, representing a -96.26% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Long-Term Debt Ray Co since 2006 – with annual values, charts, and detailed analysis.

Long-term debt represents obligations due after one year. It is a key component of a company's capital structure and leverage.

Long-Term Debt's KRW is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Long-Term Debt's Ray Co historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Balance Sheet — Ray Co

All Key Metrics — Ray Co